Page last updated: 2024-09-05

Chromone-3-carboxylic acid and iproniazid

Chromone-3-carboxylic acid has been researched along with iproniazid in 2 studies

Compound Research Comparison

Studies
(Chromone-3-carboxylic acid)
Trials
(Chromone-3-carboxylic acid)
Recent Studies (post-2010)
(Chromone-3-carboxylic acid)
Studies
(iproniazid)
Trials
(iproniazid)
Recent Studies (post-2010) (iproniazid)
6011,785882

Protein Interaction Comparison

ProteinTaxonomyChromone-3-carboxylic acid (IC50)iproniazid (IC50)
Cytochrome P450 3A4Homo sapiens (human)6.85
Cytochrome P450 2D6Homo sapiens (human)7.97
Amine oxidase [flavin-containing] BRattus norvegicus (Norway rat)7.5
Amine oxidase [flavin-containing] A Rattus norvegicus (Norway rat)5
Amine oxidase [flavin-containing] AHomo sapiens (human)5.7032
Amine oxidase [flavin-containing] BHomo sapiens (human)5.9633
C-X-C chemokine receptor type 3Homo sapiens (human)6.56
Sigma intracellular receptor 2Rattus norvegicus (Norway rat)7.5

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alcaro, S; Borges, F; Gaspar, A; Milhazes, N; Orallo, F; Ortuso, F; Uriarte, E; Yáñez, M1
Borges, F; Fonseca, A; Gaspar, A; Milhazes, N; Reis, J; Uriarte, E; Viña, D1

Other Studies

2 other study(ies) available for Chromone-3-carboxylic acid and iproniazid

ArticleYear
Chromone-2- and -3-carboxylic acids inhibit differently monoamine oxidases A and B.
    Bioorganic & medicinal chemistry letters, 2010, May-01, Volume: 20, Issue:9

    Topics: Binding Sites; Chromones; Computer Simulation; Humans; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Protein Isoforms

2010
Chromone 3-phenylcarboxamides as potent and selective MAO-B inhibitors.
    Bioorganic & medicinal chemistry letters, 2011, Jan-15, Volume: 21, Issue:2

    Topics: Animals; Cell Line; Chromones; Humans; Inhibitory Concentration 50; Models, Molecular; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neurodegenerative Diseases; Protein Isoforms; Structure-Activity Relationship

2011